
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE532CB88AF1F6C3052CB800272D5F04.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jeccr">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372207/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Experimental &amp; Clinical Cancer Research : CR">
<meta name="citation_title" content="B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer">
<meta name="citation_author" content="Giulia Cattaneo">
<meta name="citation_author_institution" content="Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA">
<meta name="citation_author_institution" content="Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA USA">
<meta name="citation_author" content="Marco Ventin">
<meta name="citation_author_institution" content="Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA">
<meta name="citation_author_institution" content="Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA USA">
<meta name="citation_author" content="Shahrzad Arya">
<meta name="citation_author_institution" content="Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA">
<meta name="citation_author_institution" content="Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA USA">
<meta name="citation_author" content="Cedric Bailey">
<meta name="citation_author_institution" content="Department of Pathology &amp; Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA USA">
<meta name="citation_author" content="Venkata Rao Vantaku">
<meta name="citation_author_institution" content="Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA">
<meta name="citation_author" content="Jingyu Jia">
<meta name="citation_author_institution" content="Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA">
<meta name="citation_author" content="Maoyang Qi">
<meta name="citation_author_institution" content="Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA USA">
<meta name="citation_author" content="Luke Maggs">
<meta name="citation_author_institution" content="Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA">
<meta name="citation_author" content="Xinhui Wang">
<meta name="citation_author_institution" content="Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA">
<meta name="citation_author" content="Sareh Parangi">
<meta name="citation_author_institution" content="Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA">
<meta name="citation_author" content="Soldano Ferrone">
<meta name="citation_author_institution" content="Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA">
<meta name="citation_author" content="Cristina R Ferrone">
<meta name="citation_author_institution" content="Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA USA">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="44">
<meta name="citation_firstpage" content="248">
<meta name="citation_doi" content="10.1186/s13046-025-03475-8">
<meta name="citation_pmid" content="40847369">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372207/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372207/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372207/pdf/13046_2025_Article_3475.pdf">
<meta name="description" content="Anaplastic thyroid cancer (ATC) is a rare and aggressive malignancy with poor survival and no available effective therapy. This unmet clinical need led us to investigate chimeric antigen receptor (CAR) T cells s as potential treatment option for ...">
<meta name="og:title" content="B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Anaplastic thyroid cancer (ATC) is a rare and aggressive malignancy with poor survival and no available effective therapy. This unmet clinical need led us to investigate chimeric antigen receptor (CAR) T cells s as potential treatment option for ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372207/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372207">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s13046-025-03475-8"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13046_2025_Article_3475.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372207%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372207/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372207/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372207/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jeccr.png" alt="Journal of Experimental &amp; Clinical Cancer Research : CR logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Experimental &amp; Clinical Cancer Research : CR" title="Link to Journal of Experimental &amp; Clinical Cancer Research : CR" shape="default" href="https://jeccr.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Exp Clin Cancer Res</button></div>. 2025 Aug 22;44:248. doi: <a href="https://doi.org/10.1186/s13046-025-03475-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s13046-025-03475-8</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Exp%20Clin%20Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Exp%20Clin%20Cancer%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Exp%20Clin%20Cancer%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Exp%20Clin%20Cancer%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cattaneo%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Giulia Cattaneo</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Giulia Cattaneo</span></h3>
<div class="p">
<sup>1</sup>Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA </div>
<div class="p">
<sup>2</sup>Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cattaneo%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Giulia Cattaneo</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ventin%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Marco Ventin</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Marco Ventin</span></h3>
<div class="p">
<sup>1</sup>Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA </div>
<div class="p">
<sup>2</sup>Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ventin%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marco Ventin</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arya%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Shahrzad Arya</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Shahrzad Arya</span></h3>
<div class="p">
<sup>1</sup>Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA </div>
<div class="p">
<sup>2</sup>Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arya%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shahrzad Arya</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bailey%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Cedric Bailey</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Cedric Bailey</span></h3>
<div class="p">
<sup>3</sup>Department of Pathology &amp; Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bailey%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cedric Bailey</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vantaku%20VR%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Venkata Rao Vantaku</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Venkata Rao Vantaku</span></h3>
<div class="p">
<sup>4</sup>Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vantaku%20VR%22%5BAuthor%5D" class="usa-link"><span class="name western">Venkata Rao Vantaku</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jia%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Jingyu Jia</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Jingyu Jia</span></h3>
<div class="p">
<sup>1</sup>Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jia%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jingyu Jia</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qi%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Maoyang Qi</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Maoyang Qi</span></h3>
<div class="p">
<sup>2</sup>Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qi%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maoyang Qi</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maggs%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Luke Maggs</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Luke Maggs</span></h3>
<div class="p">
<sup>1</sup>Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maggs%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Luke Maggs</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Xinhui Wang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Xinhui Wang</span></h3>
<div class="p">
<sup>1</sup>Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xinhui Wang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Parangi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Sareh Parangi</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Sareh Parangi</span></h3>
<div class="p">
<sup>4</sup>Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Parangi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sareh Parangi</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ferrone%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Soldano Ferrone</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Soldano Ferrone</span></h3>
<div class="p">
<sup>1</sup>Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ferrone%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Soldano Ferrone</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ferrone%20CR%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Cristina R Ferrone</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Cristina R Ferrone</span></h3>
<div class="p">
<sup>2</sup>Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ferrone%20CR%22%5BAuthor%5D" class="usa-link"><span class="name western">Cristina R Ferrone</span></a>
</div>
</div>
<sup>2,</sup><sup>âœ‰</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Division of Gastrointestinal and Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA </div>
<div id="Aff2">
<sup>2</sup>Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA USA </div>
<div id="Aff3">
<sup>3</sup>Department of Pathology &amp; Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA USA </div>
<div id="Aff4">
<sup>4</sup>Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA USA </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>âœ‰</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 15; Accepted 2025 Jul 7; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Â© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the articleâ€™s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleâ€™s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>. The Creative Commons Public Domain Dedication waiver (<a href="https://creativecommons.org/publicdomain/zero/1.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372207Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40847369/" class="usa-link">40847369</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Anaplastic thyroid cancer (ATC) is a rare and aggressive malignancy with poor survival and no available effective therapy. This unmet clinical need led us to investigate chimeric antigen receptor (CAR) T cells s as potential treatment option for this malignant disease. As target tumor antigens of our CAR T cell therapy, we selected the chondroitin sulfate proteoglycan 4 (CSPG4) and the B7-homolog 3 (B7-H3), as they are both highly and homogeneously expressed on different types of thyroid carcinoma cell lines and tissues, including ATC. Importantly, both CSPG4 and B7-H3 have a low distribution on normal tissues, thus limiting â€˜on-target off-tumorâ€™ CAR T-related toxicities.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">We generated CSPG4-specific and B7-H3-specific CAR T cells by utilizing a second-generation CAR construct comprised of a CD28 costimulatory domain and tested their antitumor activity in vitro and in an orthotopic xenograft murine model of ATC.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">We demonstrated that thyroid cancer cells are specifically recognized and effectively eradicated in vitro by CSPG4-targeted and B7-H3-targeted CAR T cells. Additionally, both CAR T cell types were able to mediate significant control or complete eradication of primary ATC tumors when mice were treated with CSPG4 CAR T cells or B7-H3 CAR T cells, respectively.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par4">Overall, in this study we identified CSPG4 and B7-H3 as valuable target antigens in thyroid cancer and demonstrated that CAR T cell immunotherapy can be a valuable therapeutic option for ATC patients. Our findings provide the translational basis for exploring CAR T cell immunotherapies targeting CSPG4 and B7-H3 with ATC patients who do not respond or relapse after first line treatment.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s13046-025-03475-8.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Anaplastic thyroid cancer, Immunotherapy, CAR T, CSPG4, B7-H3</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par5">The clinical outcome of thyroid cancer patients is strictly related to the tumor pathological subtype. Differentiated thyroid cancers, which can be classified as papillary thyroid carcinoma (PTC), and follicular thyroid carcinoma (FTC) represent most cases and respond well to standard treatments [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. In contrast, patients with poorly differentiated tumors have a worse clinical outcome. In particular, anaplastic thyroid cancer (ATC) has the highest mortality rate (close to 100%) among all thyroid cancer subtypes [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Local disease progression and distant metastases rapidly occur, and most ATC patients inevitably succumb to their disease, with a median survival rate of 6 months [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>].</p>
<p id="Par6">Currently available therapies for ATC are not effective or provide only limited clinical benefits [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Patients with advanced disease harboring BRAF-mutated tumors can benefit from the FDA-approved combination of dabrafenib (BRAF inhibitor) and trametinib (MEK inhibitor) [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. However, most patients do not achieve a complete response and experience disease progression because of the development of therapeutic resistance.</p>
<p id="Par7">To address this unmet clinical need, we investigated the therapeutic potential of an immunotherapeutic strategy based on the use of T cells specifically redirected with a chimeric antigen receptor (CAR). CARs are recombinant proteins comprised of an extracellular domain in most cases derived from the single chain variable fragment (scFv) of a monoclonal antibody (mAb), which mediates the specific binding with a target tumor antigen (TA) selectively expressed on cancer cells, and an intracellular portion which includes the CD3Î¶ signaling domain and one or more co-stimulatory domains [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>].</p>
<p id="Par8">As target TAs of our CAR T cell-based therapy we selected the chondroitin sulfate proteoglycan 4 (CSPG4) and the B7 homolog 3 (B7-H3). Both TAs have been shown to be functionally involved in tumor growth, disease progression, and metastatic spread in different types of solid tumors [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>â€“<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>] and overexpression of either antigen is a poor prognostic factor in solid cancer patients, including ATC [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Due to their homogeneous distribution across several solid tumors, CSPG4 and B7-H3 represent promising and attractive targets for CAR-redirected T cells, and their limited distribution in normal tissues increases the safety profile of this immunotherapeutic strategy [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. In our previous work we have reported the strong antitumor activity of B7-H3 CAR T cells and CSPG4-CAR T cells against different types of solid cancers in vitro and in murine models as monotherapy as well as in combination with radiation therapy [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>â€“<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>].</p>
<p id="Par9">In this study, we demonstrate the preclinical therapeutic potential of targeting CSPG4 and B7-H3 with CAR T cells for the treatment of anaplastic thyroid cancer.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Cell lines</h3>
<p id="Par10">The human ATC cell line 8505c (BRAF, NF2, TERT and TP53 mutated) and the human PTC cell line BCPAP (BRAF, TERT and TP53 mutated) were purchased from DSMZ. The human ATC cell line SW1736 (BRAF, TERT, TP53 and TSH3 mutated) was kindly provided by Dr. S. Parangi (Massachusetts General Hospital).The human 2Â C-HCC hurthle cell carcinoma cell line was generated from a patient-derived xenograft murine model. The 8505c cell line was transduced with a lentiviral vector encoding green fluorescent protein (GFP) and luciferase (Luc) and referred to as 8505c-GFP.Luc. Viral supernatant was produced by transfection of HEK293T cells (purchased from ATCC) with the pMD2.G plasmid (envelope), the psPAX2 plasmid (gag-pol), and the the GFP.Luc plasmid (kindly provided by Dr. J Franses, Massachusetts General Hospital). Thyroid cancer cell lines were cultured in Dulbecco Modified Eagle Medium (DMEM, Sigma-Aldrich, Cat# D6429) supplemented with 10% fetal bovine serum (FBS) (GeminiBio, Cat# <a href="https://www.ncbi.nlm.nih.gov/protein/S11150" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">S11150</a>), in a humidified 5% CO2 incubator at 37Â Â°C. The human pancreatic cancer cell line PDAC6, previously generated by Dr. CR. Ferrone from the ascites of a pancreatic cancer patient, was cultured in DMEM supplemented with 10% FBS [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. The Jurkat and MDA-MB-231 cell lines were purchased from ATCC and cultured in RPMI-1640 (Corning<sup>Â®</sup>, Cat# 10-043-CVR) supplemented with 10% FBS.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Immunohistochemistry</h3>
<p id="Par11">The tissue microarray (TMA) slide was purchased from TissueArray (ID #TH208a) and treated according to the IHC staining procedure which has been set up and optimized by the Pathology Core at the Massachusetts General Hospital. As a first step, the slide was baked overnight to ensure optimal adhesion of the tissue to the slide. Then, the slide was warmed up to 91Â Â°C and treated with CC2 retrieval solution (NaCit) (Ventana, Cat# 950â€‰âˆ’â€‰223). The primary CSPG4-specific mouse anti-human 763.74 mAb, produced by Dr. S. Ferrone from the 763.74 hybridoma cell line, was utilized at the concentration of 4Â Âµg/ml and incubated for 40Â min at 37Â Â°C. Anti-mouse HRP (Ventana, Cat# 760â€“4311) was utilized asdetection method and incubated for 60Â min with the primary antibody. The reaction was visualized with DAB chromogen substrate (ChromoMap DAB Kit (RUO), Roche, Cat# 760â€‰âˆ’â€‰159) and bluing reagent (Ventana, Cat# 760â€“2037), which were applied as counterstain for 60Â min. Cover slips were added using histological mounting medium (Fisher Scientific, Cat# SP15-100). The slide was imaged with a digital slide scanner (Pannoramic 250, 3D Histech, Hungary) and visualized using the NDP.view2 Viewing software. CSPG4 expression was evaluated by a board-certified attending pathologist, by using a standard scoring system. Specifically, the score indicating the percentage of stained cells was defined as 0, 1, 2 or 3 when the percentage of positive cells was 0, 1â€“29, 30â€“59 or 60â€“100, respectively. The score indicating the intensity of staining was defined as 0, 1, 2 or 3 when the intensity was negative, weak, intermediate or strong, respectively [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. The overall score was calculated by adding the score of percentage and the score of intensity together to generate a scaled score of CSPG4 expression, defined as follows: negative (0), weak (1â€“2), intermediate (3â€“4) or strong (5â€“6) [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>].</p></section><section id="Sec5"><h3 class="pmc_sec_title">CAR T cell generation</h3>
<p id="Par12">The B7-H3-specific CAR construct was generated by using the scFv derived from the 376.96 mouse mAb, an IgG2 which specifically recognizes a B7-H3 epitope, while the CSPG4-specific CAR construct was generated by using the scFv derived from the 763.74 mouse mAb, an IgG1 which specifically recognizes a CSPG4 epitope [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>â€“<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. CAR T cells were generated as previously described [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Briefly, peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation (Lymphoprepâ„¢, STEMCELL, Cat# 18061) of buffy coats obtained from normal donors (Research Blood Components) and plated in a 24-well non-treated tissue culture plate (ThermoFisher Scientific, Cat# 144530) pre-coated with anti-CD3 Ab (Miltenyi Biotec, clone OKT3, Cat# 130-093-387) at the concentration of 1Â Âµg/ml and anti-CD28 Ab at the concentration of 1Â Âµg/ml (BD Bioscience, Cat# 556620), to induce T cell activation. IL-7 (PeproTech<sup>Â®</sup>, Cat# 200-07) and IL-15 (PeproTech<sup>Â®</sup>, Cat# 200â€‰âˆ’â€‰15) were added to the culture medium at the concentration of 10ng/ml and 5ng/ml, respectively. Retroviral supernatant was added to retronectin-coated tissue culture plates (Takara Bio, Cat# T100A) and centrifuged at 2000Â g for 90Â min. After removal of the viral supernatant, activated T cells were plated at the concentration of 4â€‰Ã—â€‰10<sup>5</sup> cells per well, and centrifuged at 1000Â g for 10Â min. Following a 48Â h incubation, fresh culture medium supplemented with IL-7 andIL-15 was added to allow CAR T cell expansion. Retroviral supernatants utilized for the transduction of human T cells were produced by transfection of HEK293T cells with the RDF plasmid (envelope), the PegPam3 plasmid (gag-pol), and the retroviral vector encoding the CSPG4-specific CAR, B7-H3-specific CAR or CD19-specific CAR kindly provided by Dr. Gianpietro Dotti (University of North Carolina at Chapel Hill, Chapel Hill, NC, USA).</p></section><section id="Sec6"><h3 class="pmc_sec_title">Coculture experiments</h3>
<p id="Par13"><strong><em>3-(4</em></strong>,<strong><em>5-dimethylthiazol-2-yl)-2</em></strong>,<strong><em>5-diphenyl-2Â H-tetrazolium bromide (MTT) assay.</em></strong> Cancer cells were seeded in 96-well tissue culture plates at the concentration of 5000 cells perwell. CAR T cells were added to the plate at multiple effector (CAR T) to target (cancer) ratios without the addition of exogenous cytokines, and cultured for 72Â h. At the end of the incubation, cancer cell viability was assessed by MTT assay (Millipore Sigma, Cat# M5655) according to manufacturerâ€™s instructions.</p>
<p id="Par14"><strong><em>Live cell-imaging.</em></strong> 8505c cells were plated in a 96-well tissue culture plate at the concentration of 5000 cells per well. CAR T cells were labeled with the PKH26 Red Fluorescent Cell Membrane Dye (Millipore Sigma, Cat# PKH26GL) according to manufacturerâ€™s instructions and added to the cell culture without the addition of exogenous cytokines. Tumor cell proliferation was monitored using an Incucyte<sup>Â®</sup> SX5 Live-Cell Analysis Instrument over a 5-day incubation.</p>
<p id="Par15"><strong><em>Flow cytometry.</em></strong> Jurkat cells were labeled with the PKH26 Red Fluorescent Cell Membrane Dye according to manufacturerâ€™s instructions and plated in 96-well tissue culture plate at the concentration of 5000 cells per well. CAR T cells were added at the indicated effector to target ratios and incubated for 72Â h. At the end of the incubation, cells were collected and the number of residual Jurkat cells was determined by flow cytometry by utilizing propidium iodide (PI) as viability marker.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Effector cytokines release assay</h3>
<p id="Par16">Target cells cells were seeded in 24-well tissue culture plates at the concentration of 50.000 cells per well. CAR T cells were added to the cell culture at the 1:1 effector to target ratio without the addition of exogenous cytokines. Following a 24-hour incubation period, cell culture supernatants were collected, and T cell effector cytokines were measured utilizing a bead-based immunoassay (LEGENDplexâ„¢ V-Bottom Multiplex Assay kit for Human CD8/NK Panel, Cat# 741065) according to manufacturerâ€™s instructions.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Flow cytometry</h3>
<p id="Par17">CSPG4 and B7-H3 expression on thyroid cancer cells was assessed by using the CSPG4-specific 763.74 and the B7-H3-specific 376.96 mouse anti-human mAbs at the concentration of 1Âµg/ml. Following a 45-minute incubation at 4Â°C with the primary antibodies, cells were washed with PBS containing 0.5% BSA and stained with a FITC-conjugated goat anti-mouse secondary antibody (Jackson ImmunoResearch, Cat# 115-095-003) (1:100 dilution) for detection. B7-H3 CAR T cell transduction efficiency was assessed by utilizing a FITC-Labeled Human B7-H3 protein (4Ig) (Acro Biosystem, Cat# B7B-HF2E7) at the concentration of 2Âµg/ml, or by using an AlexaFluor 647-conjugated F(abâ€™) â‚‚ fragment goat anti-mouse IgG F(abâ€™)â‚‚ - specific (Jackson ImmunoResearch, Cat# 115-606-072); CSPG4 CAR T cell transduction efficiency was assessed by utilizing the MK2-23 anti-idiotype at the concentration of 1Â Âµg/ml. Mouse anti-human PacificBlue-conjugated anti-CD69 mAb (Biolegend, Cat# 310919, 1:100 dilution) was utilized to measure CD69 expression on CAR T cells. Mouse anti-human PE-Cy7-conjugated anti-CD3 mAb (Biolegend, Cat# 344815, 1:100 dilution) and PE-conjugated anti-CD45 (Biolegend, Cat# 368509, 1:100 diluition) were utilized to detect the presence of T cells in the blood of mice and CountBrightâ„¢ Absolute Counting Beads (ThermoFisher Scientific, Cat# <a href="https://www.ncbi.nlm.nih.gov/nuccore/C36950" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">C36950</a>) were added to calculate the number of circulating T cells. Samples were acquired with Cytek<sup>Â®</sup> Aurora Flow Cytometry System and results were analyzed utilizing FlowJo<sup>â„¢</sup> 10.9 software.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Orthotopic xenograft murine model of ATC</h3>
<p id="Par18">All mouse experiments were performed in accordance with Institutional Animal Care and Use Committee (IACUC) guidelines.</p>
<p id="Par19"><strong><em>Mice.</em></strong> Female NOD-<em>scid</em> IL2Rgamma<sup>null</sup> (NSG) 8â€“10 weeks old mice were purchased from the Jackson laboratory (Strain #: 005557) and housed in the Animal Core Facility at the Massachusetts General Hospital.</p>
<p id="Par20"><strong><em>Orthotopic model.</em></strong> The ATC orthotopic murine model was generated as previously described [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. Briefly, a horizontal incision was performed to expose the central part of the neck. Salivary glands were reflected laterally, and overlaying muscles were dissected away from the right thyroid. The 8505c-GFP.Luc cell line (500.000 cells/mouse resuspended in 5ul of PBS) was injected into the right thyroid by utilizing a Hamilton syringe. Following the injection, the needle was slowly retracted, and the salivary gland were relocated to their original position. The incision was closed with continuous suture and antibiotic cream was applied to prevent wound infection.</p></section><section id="Sec10"><h3 class="pmc_sec_title">Bioluminescence imaging</h3>
<p id="Par21">Tumor growth was monitored by Bioluminescence Imaging (BLI). Mice were anesthetized using 2% isoflurane in oxygen and intraperitoneally injected with D-luciferin Firefly. Fluorescence intensity was measured by AMI HTX in vivo imaging system (Spectral Instruments Imaging). Image processing and the quantification of photon flux was performed with Aura Imaging software.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par22">Data were analyzed by using GraphPad Prism 9 software (VERSION 9.5.1) and presented as mean valuesâ€‰Â±â€‰SD of three independent experiments. One-way ANOVA with Tukeyâ€™s multiple comparison test was utilized to determine statistical significance in the comparison among groups. Kaplan-Meier survival curves were analyzed by log-rank test. Significance is represented in graphs as ns for not significant, * for <em>p</em>â€‰â‰¤â€‰0.05, *** for <em>p</em>â€‰â‰¤â€‰0.001, **** for <em>p</em>â€‰â‰¤â€‰0.0001. CSPG4 and B7-H3 mRNA expression levels were obtained from a publicly available database (accession number <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126698" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE126698</a>) which includes RNA sequencing data obtained from primary thyroid tumors (<em>n</em>â€‰=â€‰22), including ATC, FTC and PTC, and normal thyroid tissues (<em>n</em>â€‰=â€‰6). RNA expression data were analyzed by utilizing the R package GEOquery.</p></section></section><section id="Sec12"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec13"><h3 class="pmc_sec_title">CSPG4 is highly and homogeneously expressed across different types of thyroid cancers</h3>
<p id="Par23">To investigate the potential clinical relevance of targeting CSPG4, we first evaluated its expression profile across thyroid cancers. We started by assessing <em>CSPG4</em> mRNA expression level by utilizing a publicly available database (accession number <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126698" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE126698</a>) [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>] which includes human samples of anaplastic thyroid cancer (ATC), follicular thyroid carcinoma (FTC), papillary thyroid carcinoma (PTC), and normal thyroid tissues as control. ATC samples demonstrated a higher CSPG4 expression, with some variability across patients, compared to FTC and PTC samples, in which the expression level was similar to the one observed in normal thyroid tissues (Fig.Â <a href="#Fig1" class="usa-link">1</a>A). To determine whether high mRNA levels correlate with protein expression, we evaluated the presence of CSPG4 on human tissue samples of thyroid cancers. CSPG4 expression was evaluated using an immunoreactivity score assessment. The analyzed cancer samples showed CSPG4 expression that was either strong (PTCâ€‰=â€‰11/25, FTCâ€‰=â€‰7/22, ATCâ€‰=â€‰1/12), intermediate (PTCâ€‰=â€‰11/25, FTCâ€‰=â€‰15/22, ATCâ€‰=â€‰11/12), or weak (PTCâ€‰=â€‰3), with patterns of expression including cytoplasmic (43 of 59 cancer samples) and combined membranous and cytoplasmic (16 of 59 cancer samples); contrarily, the nine non-cancer thyroid samples demonstrated low or negative CSPG4 expression (Fig.Â <a href="#Fig1" class="usa-link">1</a>B, C, Supplementary Fig.Â <a href="#MOESM1" class="usa-link">1</a>A, B). Patientâ€™s demographic information and detailed score assessment is described in Supplementary Table <a href="#MOESM1" class="usa-link">1</a>.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372207_13046_2025_3475_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a81e/12372207/a41aea2e41c9/13046_2025_3475_Fig2_HTML.jpg" loading="lazy" id="d33e517" height="580" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CSPG4 is highly and homogeneously expressed in thyroid cancers. <strong>(A)</strong> Box plot showing <em>CSPG4</em> mRNA expression level in patients with anaplastic thyroid cancer (ATC), follicular thyroid carcinoma (FTC), papillary thyroid carcinoma (PTC), and in normal thyroid tissues (NT). Data were analyzed by utilizing a publicly available database (accession number <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126698" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE126698</a>). <strong>(B)</strong> Representative images of primary thyroid tumors demonstrating high expression of CSPG4, assessed by IHC staining performed with the CSPG4-specific mAb 763.74 (4Â Âµg/mL) (400x, scale bar 50Â Î¼m). <strong>(C)</strong> Box plot summarizing the overall score of CSPG4 expression on primary thyroid tumors, assessed by quantifying the percentage of positive stained cells and the intensity of expression. <strong>(D)</strong> Membrane expression of CSPG4 on human thyroid cancer cell lines assessed by flow cytometry by utilizing the CSPG4-specific 763.74 mAb; the MK2.23 mAb was utilized as isotype control</p></figcaption></figure></section><section id="Sec14"><h3 class="pmc_sec_title">CAR T cells specifically recognize and effectively eliminate thyroid cancer cells in vitro</h3>
<p id="Par25">To investigate the in vitro antitumor activity of CSPG4-targeted CAR T cells, we first assessed CSPG4 membrane expression on 4 human thyroid cancer cell lines, including 8505c and SW1736 (ATC), 2Â C-HCC (hurthle cell carcinoma) and BCPAP (PTC). We found that CSPG4 was highly expressed on all the analyzed cell lines, with a mean of 84â€‰Â±â€‰22% of positive stained cells (Fig.Â <a href="#Fig1" class="usa-link">1</a>D).</p>
<p id="Par26">We successfully generated CSPG4 CAR T cells from three normal donors, with a mean transduction efficiency of 65â€‰Â±â€‰10% (Fig.Â <a href="#Fig2" class="usa-link">2</a>A, B). Next, we tested the in vitro antitumor activity of CSPG4 CAR T cells by co-culturing them with thyroid cancer cells at multiple effector (CAR T) to target (cancer cells) (E: T) ratios, ranging from 1:1 to 1:32. CSPG4 CAR T cells demonstrated strong antitumor activity against all the tested cell lines, by achieving near complete eradication of target cells at high ratios (cancer cell lysis of 72.2â€‰Â±â€‰15.6% at the 1:1 E: T and 50.3â€‰Â±â€‰20.7% at the 1:2 E: T) (Fig.Â <a href="#Fig2" class="usa-link">2</a>C). We observed that the percentage of cancer cell killing was lower when CSPG4 CAR T cells were cocultured with the SW1736 and BCPAP cell lines, as compared to the 8505c and 2C-HCC cell lines. A potential explanation for this difference might be related to the level of CSPG4 expression, which was found to be lower on SW1736 and BCPAP cells (51% of positive cells with an MFI of 10764 and 90% of positive cells with an MFI of 68170, respectively), as compared to 8505c and 2C-HCC cells (100% of positive cells with an MFI of 103244 and 97% of positive cells with an MFI of 90264, respectively). This hypothesis was confirmed by the positive trend observed between target antigen expression and CAR T cell-mediated killing (Supplementary Fig.Â <a href="#MOESM1" class="usa-link">1</a>C). To prove the lack of CAR T cell-associated â€˜off-tumorâ€™ toxicity CSPG4 CAR T cells were cocultured with Jurkat cells and the pancreatic cell line PDAC6, which do not express CSPG4 (Supplementary Fig.Â <a href="#MOESM1" class="usa-link">1</a>E). As demonstrated in Fig.Â <a href="#Fig2" class="usa-link">2</a>C and in Supplementary Fig.Â <a href="#MOESM1" class="usa-link">1</a>F and G, no killing was observed in these experimental conditions. Moreover, CAR T cells cocultured with Jurkat cells did not show signs of activation, as indicated by lack of CD69 upregulation, as compared to CAR T cells cocultured with CSPG4-expressing 8505c cells (Supplementary Fig.Â <a href="#MOESM1" class="usa-link">1</a>H). The specificity of CAR-mediated recognition and elimination of cancer cells was confirmed by the lack of killing observed when thyroid cancer cell lines were cocultured with CD19 CAR T cells. The latter were selected as control of the CAR specificity because CD19 is not expressed on thyroid cancers (Fig.Â <a href="#Fig2" class="usa-link">2</a>D). Finally, CAR engagement-specificity was further confirmed by the significantly higher release of T cell effector cytokines (IL-2, TNF-Î±, IFN-Î³) and Granzyme B mediated by CSPG4 CAR T cells when co-cultured with ATC cells (8505c, SW1736), as compared to CSPG4 CAR T cells cocultured with the CSPG4 negative Jurkat and PDAC6 cell lines (Fig.Â <a href="#Fig2" class="usa-link">2</a>E).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372207_13046_2025_3475_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a81e/12372207/80f7e7b5b365/13046_2025_3475_Fig3_HTML.jpg" loading="lazy" id="d33e584" height="361" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CSPG4 CAR T cells specifically recognize and effective eradicate thyroid cancer cells in vitro. <strong>A)</strong> Schematic representation of the CSPG4-specific CAR construct. <strong>B)</strong> Representative flow cytometric histogram demonstrating CSPG4 CAR T cell transduction efficiency. <strong>C)</strong> Cumulative curves demonstrating the percentage of cancer cell killing mediated by CSPG4 CAR T cells against 4 thyroid cancer cell lines and the pancreatic cancer cell line PDAC6 after a 72-hour coculture period. <strong>D)</strong> CD19 CAR T cell-mediated antitumor activity against thyroid cancer cell lines. <strong>E</strong>) Levels of effector cytokines released in the cell culture supernatant by CAR T cells after a 24-hour coculture with 8505c and SW1736 cells (CSPG4 positive) or Jurkat and PDAC6 cells (CSPG4 negative). Results are shown as meanâ€‰Â±â€‰SD of <em>n</em>â€‰=â€‰3 independent experiments. Statistical analysis was performed by one-way ANOVA multiple comparison test. ***p-valueâ€‰â‰¤â€‰0.001, ****p-valueâ€‰â‰¤â€‰0.0001</p></figcaption></figure></section><section id="Sec15"><h3 class="pmc_sec_title">CSPG4 CAR T cells effectively control tumor growth and prevent the development of lung metastases in mice orthotopically grafted with ATC tumors</h3>
<p id="Par28">To confirm in vivo the antitumor activity of CSPG4 CAR T cells, we tested their ability to eradicate thyroid tumors in a xenograft murine model of ATC. The 8505c-GFP.Luc ATC cell line was orthotopically grafted in the right thyroid of NSG mice. Fifteen days following cancer cell grafting the presence of tumors was confirmed by bioluminescence imaging (BLI), and mice were treated with CSPG4 CAR T cells or CD19 CAR T cells, administered as a single dose by tail vein injection (Fig.Â <a href="#Fig3" class="usa-link">3</a>A). Fifteen days after CAR T cell administration, mice were sacrificed and examined for the presence of tumors. We observed that CSPG4 CAR T cells were able to significantly control tumor growth compared to control groups, as demonstrated by macroscopical observation, as well as by a significant reduction of tumor weight (Fig.Â <a href="#Fig3" class="usa-link">3</a>B, C).</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372207_13046_2025_3475_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a81e/12372207/568718b2e941/13046_2025_3475_Fig4_HTML.jpg" loading="lazy" id="d33e640" height="376" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CSPG4 CAR T cells effectively control ATC tumor growth and prevent the development of lung metastases in mice. <strong>(A)</strong> Schematic timeline of the in vivo experiment. <strong>(B)</strong> Representative images of mice sacrificed 15 days after CAR T cell administration and macroscopically examined for the presence of ATC tumors (<em>n</em>â€‰=â€‰3 mice/group). <strong>(C)</strong> Weight of ATC tumors collected from mice of each treatment group at the time of sacrifice. <strong>(D)</strong> Representative BLI images of lungs collected from mice of each treatment group at the time of sacrifice. <strong>(E)</strong> Weight of lungs collected from mice of each treatment group at the time of sacrifice. Statistical analysis was performed by one-way ANOVA multiple comparison test. *p-valueâ€‰â‰¤â€‰0.05, **<em>p</em>â€‰â‰¤â€‰0.01, ***p-valueâ€‰â‰¤â€‰0.001</p></figcaption></figure><p id="Par29">Additionally, since lungs are the most common metastatic site in ATC patients, we analyzed lungs collected from mice for the presence of cancer cells. As demonstrated by BLI images in Figs.Â <a href="#Fig3" class="usa-link">3</a>D and 8505c-GFP.Luc cells were not detected in the lungs of mice treated with CSPG4 CAR T cells, as opposed to control groups. This finding was also reflected in a significant lower weight of lungs collected from the CSPG4 CAR T cell group compared to controls (Fig.Â <a href="#Fig3" class="usa-link">3</a>E).</p>
<p id="Par30">Overall, our results indicate that CSPG4 CAR T cell administration has the potential to control the growth of primary ATC tumors, as well as prevent the development of metastatic spread to the lungs. However, considering that CSPG4 CAR T cells were not able to achieve complete tumor eradication, we sought to evaluate the efficacy of CAR T cells targeting a different tumor antigen. In this regard, B7 homolog 3 (B7-H3) represents a valuable alternative target since it has been found to be highly expressed in ATC tumors [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>].</p></section><section id="Sec16"><h3 class="pmc_sec_title">B7-H3-targeted CAR T cells are effective in eradicating thyroid cancer cells in vitro</h3>
<p id="Par32">To confirm the hypothesis that B7-H3 may represent a valuable target antigen for CAR T cell-based immunotherapy, we first evaluated its expression profile across thyroid cancers by utilizing the previously mentioned publicly available database (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126698" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE126698</a>). As we observed for CSPG4, B7-H3 (<em>CD276</em>) mRNA expression level was significantly higher in ATC samples, as compared to FTC, PTC, as well as normal thyroid tissues (Fig.Â <a href="#Fig4" class="usa-link">4</a>A). By utilizing the previously described thyroid cancer cell lines, we found that B7-H3 had a more homogenous and intense expression than CSPG4 (100% and 84â€‰Â±â€‰22% of positive stained cells with a mean fluorescence intensity of 68106 and 483930 for B7-H3 and CSPG4, respectively) (Fig.Â <a href="#Fig4" class="usa-link">4</a>B, C).</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372207_13046_2025_3475_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a81e/12372207/f1bdd547411f/13046_2025_3475_Fig5_HTML.jpg" loading="lazy" id="d33e730" height="706" width="669" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>B7-H3-targeted CAR T cells effectively eradicate thyroid cancer cells in vitro. <strong>(A)</strong> Box plot showing <em>CD276</em> (B7-H3) mRNA expression level in patients with ATC, FTC, PTC, and in normal thyroid tissues (NT). Data were analyzed by utilizing a publicly available database (accession number <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126698" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE126698</a>). <strong>(B)</strong> and <strong>(C)</strong> Percentage and intensity of membrane B7-H3 expression on human thyroid cancer cell lines assessed by flow cytometry. B7-H3 expression was determined by utilizing the B7-H3-specific 376.96 mAb; the F3C.25 mAb was utilized as isotype control. <strong>(D)</strong> Schematic representation of the B7-H3-specific CAR construct. <strong>(E)</strong> Representative flow cytometric histogram showing B7-H3 CAR T cell transduction efficiency. <strong>(F)</strong> Cumulative curves demonstrating the percentage of cancer cell killing mediated by B7-H3 CAR T cells against 4 thyroid cancer cell lines and the MDA-MB-231 B7-H3<sup>-/-</sup> or MDA-MB-231 B7-H3<sup>wt</sup> cell line after a 72-hour coculture period. <strong>(G)</strong> Levels of effector cytokines released in the cell culture supernatant by CAR T cells after a 24-hour coculture with 8505c and SW1736 cells (B7-H3 positive) or Jurkat and MDA-MB-231 B7-H3<sup>-/-</sup> cells (B7-H3 negative). <strong>(H)</strong> Live monitoring of 8505c cell growth (phase image) cocultured with either B7-H3-specific, CSPG4-specific, or CD19-specific CAR T cells (PKH26-labeled, red) for a 96Â h-coculture period at the 1:1 E: T ratio. Results are shown as meanâ€‰Â±â€‰SD of <em>n</em>â€‰=â€‰3 independent experiments. Statistical analysis was performed by unpaired t-test or one-way ANOVA multiple comparison test. *p-valueâ€‰â‰¤â€‰0.05, **p-valueâ€‰â‰¤â€‰0.01, ***p-valueâ€‰â‰¤â€‰0.001, ****p-valueâ€‰â‰¤â€‰0.0001</p></figcaption></figure><p id="Par33">Based on our findings, we genetically engineered normal donor T cells (<em>n</em>â€‰=â€‰3) with a B7-H3-specific CAR construct; mean transduction efficiency was confirmed by utilizing two different detection methods (Supplementary Fig.Â <a href="#MOESM1" class="usa-link">2</a>) (33), and it was comparable to CSPG4 CAR T cells (70â€‰Â±â€‰4% (Fig.Â <a href="#Fig2" class="usa-link">2</a>D, E). B7-H3 CAR T cells demonstrated intense in vitro antitumor activity when cocultured with thyroid cancer cell lines at high ratios (cancer cell lysis: 87.5â€‰Â±â€‰7.2% at the 1:1 E: T, 72.4â€‰Â±â€‰14.4% at the 1:2 E: T), and CAR engagement-specificity was confirmed by the release of T cell effector cytokines mediated by B7-H3 CAR T cells when co-cultured with B7-H3 positive ATC cells (Fig.Â <a href="#Fig4" class="usa-link">4</a>H). As observed for CSPG4 CAR T cells, B7-H3 CAR T cells did not show â€˜off-tumorâ€™ effect, as demonstrated by the lack of killing when cocultured with the B7-H3 negative Jurkat cell line or with the breast cancer cell line MDA-MB-231 genetically modified to knockout B7-H3 expression (MDA-MB-231 B7-H3<sup>-/-</sup>) (Fig.Â <a href="#Fig2" class="usa-link">2</a>F, Supplementary Fig.Â <a href="#MOESM1" class="usa-link">1</a>E-I).</p>
<p id="Par34">Overall, we observed that B7-H3 CAR T-mediated killing was higher compared to CSPG4 CAR T cells, indicating that B7-H3 may represent a more effective target antigen. These findings were confirmed by monitoring the growth of the 8505c cells over a 5-day co-culture in the presence of either B7-H3-specific or CSPG4-specific CAR T cells at the 1:1 ratio. The extent of killing was already appreciable after 24Â h of co-culture, with nearly complete eradication occurring at the end of the incubation period when 8505c cells were cocultured with B7-H4 CAR T cells but not with CSPG4 CAR T cells (Fig.Â <a href="#Fig4" class="usa-link">4</a>G).</p></section><section id="Sec17"><h3 class="pmc_sec_title">B7-H3 CAR T cells demonstrate superior antitumor activity compared to CSPG4 CAR T cells in an orthotopic xenograft murine model of ATC</h3>
<p id="Par36">To investigate and compare the long-term in vivo antitumor activity of B7-H3 CAR T cells and CSPG4 CAR T cells, the 8505c-GFP.Luc cell line was orthotopically grafted in NSG mice (Fig.Â <a href="#Fig5" class="usa-link">5</a>A). When the presence of tumors was confirmed by BLI, mice were randomly assigned to the different treatment groups, and CAR T cells were administered as a single dose by tail vein injection (Fig.Â <a href="#Fig5" class="usa-link">5</a>B). B7-H3 CAR T cell administration achieved complete tumor eradication in all treated mice (5/5), which remained tumor-free up to 90 days after treatment. On the other hand, CSPG4 CAR T cells mediated complete tumor eradication only in 2/5 mice and partially controlled tumor growth in 3/5 mice (Fig.Â <a href="#Fig5" class="usa-link">5</a>B, C). B7-H3 CAR T cells and CSPG4 CAR T cells demonstrated similar in vivo proliferation rates, with peak expansion 10 days following administration (Fig.Â <a href="#Fig5" class="usa-link">5</a>E), and they both prolonged the survival of mice when compared to control groups. However, as we observed in our in vitro results, B7-H3 CAR T cell treatment was more effective in eradicating ATC tumors and prolonging mice survival (Fig.Â <a href="#Fig5" class="usa-link">5</a>D), confirming the superiority of B7-H3 as target tumor antigen in ATC.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372207_13046_2025_3475_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a81e/12372207/c1af2d39de89/13046_2025_3475_Fig6_HTML.jpg" loading="lazy" id="d33e788" height="540" width="669" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>B7-H3 CAR T cells demonstrate superior antitumor activity compared to CSPG4 CAR T cells in an orthotopic murine model of ATC. <strong>(A)</strong> Schematic timeline of the in vivo experiment. <strong>(B)</strong> BLI monitoring of tumor growth in each group treated as indicated (<em>n</em>â€‰=â€‰5 mice/group). â€˜Xâ€™ denotes mice dead of disease. <strong>(C)</strong> Total photon flux as a function of time after CAR T cell administration. <strong>(D)</strong> Kaplan-Meier survival curves of mice in each treatment group. <strong>(E)</strong> CAR T cell (CD3â€‰+â€‰CD45+) expansion in peripheral blood (50ÂµL) collected from tumor-bearing mice. Statistical analysis was performed using one-way ANOVA multiple comparison test <strong>(C</strong>,<strong> E)</strong>, and log-rank test <strong>(D)</strong>. nsâ€‰=â€‰not significant, *p-valueâ€‰â‰¤â€‰0.05, ****p-valueâ€‰â‰¤â€‰0.0001</p></figcaption></figure></section></section><section id="Sec18"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par38">The design of novel and effective systemic therapies is urgently needed to prolong the survival and improve the quality of life of ATC patients. In this study we provide preclinical evidence supporting CAR T cell-based immunotherapy as a potentially effective treatment for this lethal disease.</p>
<p id="Par39">Preclinical and clinical evidence supports the rationale to investigate the efficacy of CAR T cell-based immunotherapy with advanced thyroid cancers. Indeed, Min et al. have reported that ICAM-1-redicrected CAR T cells in combination with PD-1 blockade were able to mediate strong antitumor activity against ATC cell lines in vitro and ATC patient-derived xenograft murine models [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. Furthermore, adoptive transfer of ICAM-1 CAR T cells has been proven safe and feasible in a recent Phase I clinical trial for patients with relapsed/refractory poorly differentiated and anaplastic thyroid cancers [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>].</p>
<p id="Par40">In our previous studies we have demonstrated that the tumor antigens B7-H3 and CSPG4 are highly and homogeneously expressed in different types of solid tumors, with limited distribution on normal tissues [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. This evidence, along with the pro-tumorigenic functions associated with B7-H3 and CSPG4 expressions, prompted us to develop two second generation CAR constructs designed to specifically recognize these target antigens. We have confirmed the preclinical therapeutic potential of B7-H3-targeted and CSPG4-targeted CAR T cells, by showing that they can induce effective and durable antitumor response in murine models of different types of solid tumors, including pancreatic and ovarian cancer, chordoma, glioblastoma and uveal melanoma [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>â€“<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. The available evidence showing that B7-H3 and CSPG4 are highly expressed in human ATC cell lines and tumors with a limited distribution on adjacent normal thyroid tissue, prompted us to investigate the antitumor efficacy of our CAR T cell therapies with thyroid cancers, including ATC [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. We confirmed a high and homogeneous gene and protein expression of B7-H3 and CSPG4 in different types of thyroid cancers. Interestingly, we observed that the mRNA level of both TAs was higher in ATC patients as compared to follicular and papillary thyroid cancers, suggesting a potential association between increased B7-H3 and CSPG4 expression levels with a higher degree of tumor aggressiveness. This hypothesis is supported by a previous study showing that increased CSPG4 protein expression was associated with a worse prognosis in ATC patients [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>].</p>
<p id="Par41">In this study we demonstrate that B7-H3-specific and CSPG4-specific CAR T cells are both valuable therapeutic candidates to treat ATC tumors. Our findings indicate that B7-H3 CAR T cells are more effective in eradicating ATC cells in vitro and ATC tumors in mice as compared to CSPG4 CAR T cells. One potential explanation could be related to the higher expression level of B7-H3 on thyroid cancer cells as compared to CSPG4, which might lead to a stronger CAR T cell activation. The hypothesis that CAR T cell-mediated killing correlates with the level of antigen expression is supported by the positive correlation observed between the expression levels of CSPG4 and B7-H3 on thyroid cancer cells and CAR T cell-mediated killing in vitro (Supplementary Fig.Â <a href="#MOESM1" class="usa-link">1</a>C, D). This observation might indicate that a higher tumor antigen density on target cells can lead to a stronger CAR T cell activation and enhanced cancer cell killing. The different antitumor activity might also be related to a variance in the binding affinity of the mAbs from which the two CAR constructs have been generated. The B7-H3-specific CAR was generated from the 376.96 mAb, characterized by a moderate binding affinity for the 2Ig isoform of B7-H3 (1.87â€‰Ã—â€‰10<sup>-7</sup> M) [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. On the other hand, the binding affinity of the CSPG4-specific 763.74 mAb has been found to be around 1â€‰Ã—â€‰10<sup>-8</sup> M [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Based on this observation, we can conclude that the affinity of the B7-H3 CAR might be lower than the CSPG4 CAR. Interestingly, it has been shown that CAR T cells with lower-affinity scFvs can maintain potent antitumor activity while potentially reducing off-tumor toxicity. As an example, CAR T cells with low affinity scFvs targeting HER2 and CD19 have demonstrated sustained functionality and reduced exhaustion in preclinical murin models and in leukemia patients, respectively [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Even though the evidence present in the literature might justify the enhanced efficacy of B7-H3 CAR T cells, further in-depth mechanistic studies are required to better understand the reasons underlying the observed differences in the extent of killing.</p>
<p id="Par42">As future directions, our study provides the basis to develop combinatorial therapies to enhance CAR T cell antitumor potential by increasing the expression of the target antigen, as well as to design dual-targeting CAR T cell therapy against CSPG4 and B7-H3. Simultaneous targeting of two tumor antigens represents an effective strategy to limit the development of resistance and the risk of relapse associated with tumor antigen escape. Most importantly, the identification of two suitable target antigens strongly supports the design of CAR constructs based on the â€œANDâ€ logic gating. In this instance CAR T cell activation occurs only when the two antigens are co-expressed by tumor cells. Therefore, such strategy can augment CAR T cell specificity and safety, by reducing the risk of â€œon-target off-tumorâ€- associated toxicities. Limitations of this study include the lack of an immunocompetent murine model to reflect the challenges associated with the hostile tumor microenvironment which hinder CAR T cell effector function [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Overall, our findings strongly support further investigation for the clinical translation of B7-H3- and CSPG4-targeted CAR T cell-based immunotherapies for the treatment of anaplastic thyroid cancer. Specifically, both tumor antigens should be considered when designing future clinical trials for ATC patients with BRAF wild-type tumors or patients with advanced thyroid cancers relapsed/refractory to first line target therapies.</p></section><section id="Sec19"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par43">Overall, in this study we identified CSPG4 and B7-H3 as valuable therapeutic targets in different types of thyroid carcinoma, including anaplastic thyroid cancer, a rare and lethal disease with no effective treatment. By utilizing preclinical in vitro and in vivo models we demonstrated that CAR T cell-based immunotherapy targeting either tumor antigens represent a valuable alternative treatment option for ATC patients. Our findings provide the translational basis for further exploring CAR T cell immunotherapies targeting CSPG4 and B7-H3 with ATC patients, especially for those who do not respond or relapse after first line treatments.</p></section><section id="Sec1613121212121"><h2 class="pmc_sec_title">Electronic supplementary material</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12372207/bin/13046_2025_3475_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (30.1MB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>This study and significant contribution to the application of CAR T cell-based immunotherapy are due to the landmark contributions of the late Dr. Soldano Ferrone, M.D., Ph.D. We express our gratitude to Dr. S. Ferrone for supporting this work.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>ATC</dt>
<dd><p id="Par47">Anaplastic thyroid cancer</p></dd>
<dt>B7-H3</dt>
<dd><p id="Par48">B7 homolog 3</p></dd>
<dt>BLI</dt>
<dd><p id="Par49">Bioluminescence imaging</p></dd>
<dt>CAR</dt>
<dd><p id="Par50">Chimeric antigen receptor</p></dd>
<dt>CSPG4</dt>
<dd><p id="Par51">Chondroitin sulphate proteoglycan 4</p></dd>
<dt>FDA</dt>
<dd><p id="Par52">Food and Drug Administration</p></dd>
<dt>FTC</dt>
<dd><p id="Par53">Follicular thyroid cancer</p></dd>
<dt>GFP</dt>
<dd><p id="Par54">Green fluorescent protein</p></dd>
<dt>HCC</dt>
<dd><p id="Par55">Hurthle cell carcinoma</p></dd>
<dt>mAb</dt>
<dd><p id="Par56">Monoclonal antibody</p></dd>
<dt>NSG</dt>
<dd><p id="Par57">NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ</p></dd>
<dt>PDAC</dt>
<dd><p id="Par58">Pancreatic ductal adenocarcinoma</p></dd>
<dt>PTC</dt>
<dd><p id="Par59">Papillary thyroid cancer</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Conceptualization and study design: CRF, SP, XW, GC, MV. Data collection and analysis: GC, MV, MQ, VRV. Interpretation of results and significant intellectual contribution: MV, SA, CB, VRV, JJ, LM. Analysis of IHC stained tissues: CB. Writing of original draft: GC, CRF. Project administration and supervision: CRF, XW, SP. All authors performed critical review of the manuscript and had full access to all the data included in the study. All authors contributed and approved the final version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by the National Institutes of Health / National Cancer Institute R03CA280302 (CRF), the Ruane fund at MGH (SP), the Bertarelli Foundation (SP), R01DE028172 (XW), R01CA226981 (XW), Department of Defense Idea Award W81XWH-20-PCRP-IDA (W81XWH2110433) (XW), Department of Defense Breakthrough Award Level 2 W81XWH-16-1-0500 (BC190615) (SF), R03CA223886 (SF), R03CA231766 (SF) and Department of Defense Breakthrough Award Level 4 W81XWH-20-1-0315 (BC190615) (SF) funding sources.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par44">All mouse studies were performed under a protocol (#2013N000014) approved by the Institutional Animal Care and Use Committee (IACUC) at Massachusetts General Hospital.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par45">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par46">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisherâ€™s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1â€“133.
</cite> [<a href="https://doi.org/10.1089/thy.2015.0020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4739132/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26462967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haugen%20BR,%20Alexander%20EK,%20Bible%20KC,%20Doherty%20GM,%20Mandel%20SJ,%20Nikiforov%20YE,%20et%20al.%202015%20American%20thyroid%20association%20management%20guidelines%20for%20adult%20patients%20with%20thyroid%20nodules%20and%20differentiated%20thyroid%20cancer:%20the%20American%20thyroid%20association%20guidelines%20task%20force%20on%20thyroid%20nodules%20and%20differentiated%20thyroid%20Cancer.%20Thyroid.%202016;26(1):1%E2%80%93133." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, et al. American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012;22(11):1104â€“39.
</cite> [<a href="https://doi.org/10.1089/thy.2012.0302" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23130564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Smallridge%20RC,%20Ain%20KB,%20Asa%20SL,%20Bible%20KC,%20Brierley%20JD,%20Burman%20KD,%20et%20al.%20American%20thyroid%20association%20guidelines%20for%20management%20of%20patients%20with%20anaplastic%20thyroid%20cancer.%20Thyroid.%202012;22(11):1104%E2%80%9339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Molinaro E, Romei C, Biagini A, Sabini E, Agate L, Mazzeo S, et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol. 2017;13(11):644â€“60.
</cite> [<a href="https://doi.org/10.1038/nrendo.2017.76" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28707679/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Molinaro%20E,%20Romei%20C,%20Biagini%20A,%20Sabini%20E,%20Agate%20L,%20Mazzeo%20S,%20et%20al.%20Anaplastic%20thyroid%20carcinoma:%20from%20clinicopathology%20to%20genetics%20and%20advanced%20therapies.%20Nat%20Rev%20Endocrinol.%202017;13(11):644%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Subbiah V, Kreitman RJ, Wainberg ZA, Cho JY, Schellens JHM, Soria JC, Wen PY, Zielinski CC, Cabanillas ME, Boran A, Ilankumaran P, Burgess P, Romero Salas T, Keam B. Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study. Ann Oncol. 2022 Apr;33(4):406â€“415.</cite> [<a href="https://doi.org/10.1016/j.annonc.2021.12.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9338780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35026411/" class="usa-link">PubMed</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Sterner RC, Sterner RM. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 2021;11(4):69.
</cite> [<a href="https://doi.org/10.1038/s41408-021-00459-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8024391/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33824268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sterner%20RC,%20Sterner%20RM.%20CAR-T%20cell%20therapy:%20current%20limitations%20and%20potential%20strategies.%20Blood%20Cancer%20J.%202021;11(4):69." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Kontos F, Michelakos T, Kurokawa T, Sadagopan A, Schwab JH, Ferrone CR, et al. B7-H3: an attractive target for antibody-based immunotherapy. Clin Cancer Res. 2021;27(5):1227â€“35.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-20-2584" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7925343/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33051306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kontos%20F,%20Michelakos%20T,%20Kurokawa%20T,%20Sadagopan%20A,%20Schwab%20JH,%20Ferrone%20CR,%20et%20al.%20B7-H3:%20an%20attractive%20target%20for%20antibody-based%20immunotherapy.%20Clin%20Cancer%20Res.%202021;27(5):1227%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Rolih V, Barutello G, Iussich S, De Maria R, Quaglino E, Buracco P, et al. CSPG4: A prototype oncoantigen for translational immunotherapy studies. Journal of Translational Medicine. Volume 15. BioMed Central Ltd.; 2017.</cite> [<a href="https://doi.org/10.1186/s12967-017-1250-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5494135/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28668095/" class="usa-link">PubMed</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Wang X, Wang Y, Yu L, Sakakura K, Visus C, Schwab JH, et al. CSPG4 in cancer: multiple roles. Curr Mol Med. 2010;10(4):419â€“29.
</cite> [<a href="https://doi.org/10.2174/156652410791316977" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20455858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20X,%20Wang%20Y,%20Yu%20L,%20Sakakura%20K,%20Visus%20C,%20Schwab%20JH,%20et%20al.%20CSPG4%20in%20cancer:%20multiple%20roles.%20Curr%20Mol%20Med.%202010;10(4):419%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Toda S, Sato S, Saito N, Sekihara K, Matsui A, Murayama D, Nakayama H, Suganuma N, Okubo Y, Hayashi H, Iwasaki H, Miyagi Y, Hoshino D. TROP-2, Nectin-4, GPNMB, and B7-H3 Are Potentially Therapeutic Targets for Anaplastic Thyroid Carcinoma. Cancers (Basel). 2022 Jan 24;14(3):579.</cite> [<a href="https://doi.org/10.3390/cancers14030579" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8833363/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35158847/" class="usa-link">PubMed</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Egan CE, Stefanova D, Ahmed A, Raja VJ, Thiesmeyer JW, Chen KJ, et al. CSPG4 is a potential therapeutic target in anaplastic thyroid Cancer. Thyroid. 2021;31(10):1481â€“93.
</cite> [<a href="https://doi.org/10.1089/thy.2021.0067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8917884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34078123/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Egan%20CE,%20Stefanova%20D,%20Ahmed%20A,%20Raja%20VJ,%20Thiesmeyer%20JW,%20Chen%20KJ,%20et%20al.%20CSPG4%20is%20a%20potential%20therapeutic%20target%20in%20anaplastic%20thyroid%20Cancer.%20Thyroid.%202021;31(10):1481%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Ilieva KM, Cheung A, Mele S, Chiaruttini G, Crescioli S, Griffin M, et al. Chondroitin sulfate proteoglycan 4 and its potential as an antibody immunotherapy target across different tumor types. Frontiers in Immunology. Volume 8. Frontiers Media S.A.; 2018.</cite> [<a href="https://doi.org/10.3389/fimmu.2017.01911" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5767725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29375561/" class="usa-link">PubMed</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Ventin M, Cattaneo G, Maggs L, Jia J, Arya S, Ferrone S, Wang X, Ferrone CR. B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancers. Front Oncol. 2023 Jul 7;13:1193963.</cite> [<a href="https://doi.org/10.3389/fonc.2023.1193963" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10361748/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37483496/" class="usa-link">PubMed</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Wang Y, Drum DL, Sun R, Zhang Y, Chen F, Sun F, et al. Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment. Nat Commun. 2023;14(1):5727.
</cite> [<a href="https://doi.org/10.1038/s41467-023-41282-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10504259/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37714830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Drum%20DL,%20Sun%20R,%20Zhang%20Y,%20Chen%20F,%20Sun%20F,%20et%20al.%20Stressed%20target%20cancer%20cells%20drive%20nongenetic%20reprogramming%20of%20CAR%20T%20cells%20and%20solid%20tumor%20microenvironment.%20Nat%20Commun.%202023;14(1):5727." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Geldres C, Savoldo B, Hoyos V, Caruana I, Zhang M, Yvon E, et al. T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo. Clin Cancer Res. 2014;20(4):962â€“71.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-13-2218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3944408/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24334762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Geldres%20C,%20Savoldo%20B,%20Hoyos%20V,%20Caruana%20I,%20Zhang%20M,%20Yvon%20E,%20et%20al.%20T%20lymphocytes%20redirected%20against%20the%20chondroitin%20sulfate%20proteoglycan-4%20control%20the%20growth%20of%20multiple%20solid%20tumors%20both%20in%20vitro%20and%20in%20vivo.%20Clin%20Cancer%20Res.%202014;20(4):962%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Ligorio M, Sil S, Malagon-Lopez J, Nieman LT, Misale S, Di Pilato M, et al. Stromal microenvironment shapes the intratumoral architecture of pancreatic Cancer. Cell. 2019;178(1):160â€“e17527.
</cite> [<a href="https://doi.org/10.1016/j.cell.2019.05.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6697165/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31155233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ligorio%20M,%20Sil%20S,%20Malagon-Lopez%20J,%20Nieman%20LT,%20Misale%20S,%20Di%20Pilato%20M,%20et%20al.%20Stromal%20microenvironment%20shapes%20the%20intratumoral%20architecture%20of%20pancreatic%20Cancer.%20Cell.%202019;178(1):160%E2%80%93e17527." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Du H, Hirabayashi K, Ahn S, Kren NP, Montgomery SA, Wang X, et al. Antitumor responses in the absence of toxicity in solid tumors by targeting B7-H3 via chimeric antigen receptor T cells. Cancer Cell. 2019;35(2):221â€“e2378.
</cite> [<a href="https://doi.org/10.1016/j.ccell.2019.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6645919/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30753824/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Du%20H,%20Hirabayashi%20K,%20Ahn%20S,%20Kren%20NP,%20Montgomery%20SA,%20Wang%20X,%20et%20al.%20Antitumor%20responses%20in%20the%20absence%20of%20toxicity%20in%20solid%20tumors%20by%20targeting%20B7-H3%20via%20chimeric%20antigen%20receptor%20T%20cells.%20Cancer%20Cell.%202019;35(2):221%E2%80%93e2378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Kageshita Toshiro HSOTFS. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic MAb MK2-23. Immunohistochemical analysis of the reactivity of anti-anti-idiotypic MAb with surgically removed melanoma lesions. Int J Cancer. 1995;60(3):334â€“40.
</cite> [<a href="https://doi.org/10.1002/ijc.2910600310" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7829240/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kageshita%20Toshiro%20HSOTFS.%20Human%20high%20molecular%20weight-melanoma%20associated%20antigen%20mimicry%20by%20mouse%20anti-idiotypic%20MAb%20MK2-23.%20Immunohistochemical%20analysis%20of%20the%20reactivity%20of%20anti-anti-idiotypic%20MAb%20with%20surgically%20removed%20melanoma%20lesions.%20Int%20J%20Cancer.%201995;60(3):334%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Wang X, Osada T, Wang Y, Yu L, Sakakura K, Katayama A, et al. CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer. J Natl Cancer Inst. 2010;102(19):1496â€“512.
</cite> [<a href="https://doi.org/10.1093/jnci/djq343" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2950168/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20852124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20X,%20Osada%20T,%20Wang%20Y,%20Yu%20L,%20Sakakura%20K,%20Katayama%20A,%20et%20al.%20CSPG4%20protein%20as%20a%20new%20target%20for%20the%20antibody-based%20immunotherapy%20of%20triple-negative%20breast%20cancer.%20J%20Natl%20Cancer%20Inst.%202010;102(19):1496%E2%80%93512." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Nucera C, Nehs MA, Mekel M, Zhang X, Hodin R, Lawler J, et al. A novel orthotopic mouse model of human anaplastic thyroid carcinoma. Thyroid. 2009;19(10):1077â€“84.
</cite> [<a href="https://doi.org/10.1089/thy.2009.0055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2833178/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19772429/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nucera%20C,%20Nehs%20MA,%20Mekel%20M,%20Zhang%20X,%20Hodin%20R,%20Lawler%20J,%20et%20al.%20A%20novel%20orthotopic%20mouse%20model%20of%20human%20anaplastic%20thyroid%20carcinoma.%20Thyroid.%202009;19(10):1077%E2%80%9384." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Haase J, Misiak D, Bauer M, Pazaitis N, Braun J, PÃ¶tschke R, et al. IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis. Mod Pathol. 2021;34(1):32â€“41.
</cite> [<a href="https://doi.org/10.1038/s41379-020-0630-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7806508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32719445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haase%20J,%20Misiak%20D,%20Bauer%20M,%20Pazaitis%20N,%20Braun%20J,%20P%C3%B6tschke%20R,%20et%20al.%20IGF2BP1%20is%20the%20first%20positive%20marker%20for%20anaplastic%20thyroid%20carcinoma%20diagnosis.%20Mod%20Pathol.%202021;34(1):32%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Min IM, Shevlin E, Vedvyas Y, Zaman M, Wyrwas B, Scognamiglio T, et al. CAR T therapy targeting ICAM-1 eliminates advanced human thyroid tumors. Clin Cancer Res. 2017;23(24):7569â€“83.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-17-2008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5732861/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29025766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Min%20IM,%20Shevlin%20E,%20Vedvyas%20Y,%20Zaman%20M,%20Wyrwas%20B,%20Scognamiglio%20T,%20et%20al.%20CAR%20T%20therapy%20targeting%20ICAM-1%20eliminates%20advanced%20human%20thyroid%20tumors.%20Clin%20Cancer%20Res.%202017;23(24):7569%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Gray KD, McCloskey JE, Vedvyas Y, Kalloo OR, Eshaky S, El, Yang Y, et al. PD1 Blockade enhances ICAM1-Directed CAR T therapeutic efficacy in advanced thyroid Cancer. Clin Cancer Res. 2020;26(22):6003â€“16.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-20-1523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7709864/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32887724/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gray%20KD,%20McCloskey%20JE,%20Vedvyas%20Y,%20Kalloo%20OR,%20Eshaky%20S,%20El,%20Yang%20Y,%20et%20al.%20PD1%20Blockade%20enhances%20ICAM1-Directed%20CAR%20T%20therapeutic%20efficacy%20in%20advanced%20thyroid%20Cancer.%20Clin%20Cancer%20Res.%202020;26(22):6003%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Hsu JM, Von Hofe E, Hsu YM, Shieh JH, Chaekal OK, Guarneri D, et al. Phase I study of AIC100 in relapsed and/or refractory advanced thyroid cancer and anaplastic thyroid cancer. J Clin Oncol. 2022;40:16.</cite> [<a href="https://scholar.google.com/scholar_lookup?Hsu%20JM,%20Von%20Hofe%20E,%20Hsu%20YM,%20Shieh%20JH,%20Chaekal%20OK,%20Guarneri%20D,%20et%20al.%20Phase%20I%20study%20of%20AIC100%20in%20relapsed%20and/or%20refractory%20advanced%20thyroid%20cancer%20and%20anaplastic%20thyroid%20cancer.%20J%20Clin%20Oncol.%202022;40:16." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Wang K, Osei-Hwedieh DO, Walhart TA, Hung YP, Wang Y, Cattaneo G, Ma T, Dotti G, Wang X, Ferrone S, Schwab JH. B7-H3 CAR-T cell therapy combined with irradiation is effective in targeting bulk and radiation-resistant chordoma cancer cells. J Immunother Cancer. 2025 Jan 22;13(1):e009544.</cite> [<a href="https://doi.org/10.1136/jitc-2024-009544" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11784168/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39848690/" class="usa-link">PubMed</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Pellegatta S, Savoldo B, Ianni N, Di, Corbetta C, Chen Y, PatanÃ© M et al. Constitutive and TNFÎ±-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy [Internet]. Vol. 10, Sci. Transl. Med. 2018. Available from: <a href="https://www.science.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.science.org</a></cite> [<a href="https://doi.org/10.1126/scitranslmed.aao2731" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8713441/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29491184/" class="usa-link">PubMed</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Ventin M, Cattaneo G, Arya S, Jia J, Gelmi MC, Sun Y, et al. Chimeric antigen receptor T cell with an inducible Caspase-9 suicide gene eradicates uveal melanoma liver metastases via B7-H3 targeting. Clin Cancer Res. 2024;30(15):3243â€“58.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-24-0071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11572477/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38767611/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ventin%20M,%20Cattaneo%20G,%20Arya%20S,%20Jia%20J,%20Gelmi%20MC,%20Sun%20Y,%20et%20al.%20Chimeric%20antigen%20receptor%20T%20cell%20with%20an%20inducible%20Caspase-9%20suicide%20gene%20eradicates%20uveal%20melanoma%20liver%20metastases%20via%20B7-H3%20targeting.%20Clin%20Cancer%20Res.%202024;30(15):3243%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Song P, Xu Y, Ye G. B7-H3 and ICAM-1 are potentially therapeutic targets for thyroid carcinoma. Diagn Pathol. 2024 Jun 10;19(1):77.</cite> [<a href="https://doi.org/10.1186/s13000-024-01504-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11163747/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38858715/" class="usa-link">PubMed</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Giacomini PNPFS. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants. J Immunol. 1985;135(1):696â€“702.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2582052/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Giacomini%20PNPFS.%20Analysis%20of%20the%20interaction%20between%20a%20human%20high%20molecular%20weight%20melanoma-associated%20antigen%20and%20the%20monoclonal%20antibodies%20to%20three%20distinct%20antigenic%20determinants.%20J%20Immunol.%201985;135(1):696%E2%80%93702." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Ghorashian S, Kramer AM, Onuoha S, Wright G, Bartram J, Richardson R, et al. Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR. Nat Med. 2019;25(9):1408â€“14.
</cite> [<a href="https://doi.org/10.1038/s41591-019-0549-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31477906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ghorashian%20S,%20Kramer%20AM,%20Onuoha%20S,%20Wright%20G,%20Bartram%20J,%20Richardson%20R,%20et%20al.%20Enhanced%20CAR%20T%20cell%20expansion%20and%20prolonged%20persistence%20in%20pediatric%20patients%20with%20ALL%20treated%20with%20a%20low-affinity%20CD19%20CAR.%20Nat%20Med.%202019;25(9):1408%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Liu X, Jiang S, Fang C, Yang S, Olalere D, Pequignot EC, et al. Affinity-tuned ErbB2 or EGFR chimeric antigen receptor T cells exhibit an increased therapeutic index against tumors in mice. Cancer Res. 2015;75(17):3596â€“607.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-15-0159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4560113/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26330166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20X,%20Jiang%20S,%20Fang%20C,%20Yang%20S,%20Olalere%20D,%20Pequignot%20EC,%20et%20al.%20Affinity-tuned%20ErbB2%20or%20EGFR%20chimeric%20antigen%20receptor%20T%20cells%20exhibit%20an%20increased%20therapeutic%20index%20against%20tumors%20in%20mice.%20Cancer%20Res.%202015;75(17):3596%E2%80%93607." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Xu Z, Shin HS, Kim YH, Ha SY, Won JK, Kim SJ, et al. Modeling the tumor microenvironment of anaplastic thyroid cancer: an orthotopic tumor model in C57BL/6 mice. Front Immunol. 2023;14:1187388.
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1187388" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10403231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37545523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20Z,%20Shin%20HS,%20Kim%20YH,%20Ha%20SY,%20Won%20JK,%20Kim%20SJ,%20et%20al.%20Modeling%20the%20tumor%20microenvironment%20of%20anaplastic%20thyroid%20cancer:%20an%20orthotopic%20tumor%20model%20in%20C57BL/6%20mice.%20Front%20Immunol.%202023;14:1187388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Ventin M, Cattaneo G, Maggs L, Arya S, Wang X, Ferrone CR. Implications of high tumor burden on chimeric antigen receptor T-Cell immunotherapy: A review. JAMA Oncol. 2024;10(1):115â€“21.
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2023.4504" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37943567/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ventin%20M,%20Cattaneo%20G,%20Maggs%20L,%20Arya%20S,%20Wang%20X,%20Ferrone%20CR.%20Implications%20of%20high%20tumor%20burden%20on%20chimeric%20antigen%20receptor%20T-Cell%20immunotherapy:%20A%20review.%20JAMA%20Oncol.%202024;10(1):115%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Schanda N, Sauer T, Kunz A, HÃ¼ckelhoven-Krauss A, Neuber B, Wang L, Hinkelbein M, Sedloev D, He B, Schubert ML, MÃ¼ller-Tidow C, Schmitt M, Schmitt A. Sensitivity and specificity of CD19.CAR-T cell detection by flow cytometry and PCR. Cells. 2021;10(11):3208.
</cite> [<a href="https://doi.org/10.3390/cells10113208" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8621201/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34831430/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schanda%20N,%20Sauer%20T,%20Kunz%20A,%20H%C3%BCckelhoven-Krauss%20A,%20Neuber%20B,%20Wang%20L,%20Hinkelbein%20M,%20Sedloev%20D,%20He%20B,%20Schubert%20ML,%20M%C3%BCller-Tidow%20C,%20Schmitt%20M,%20Schmitt%20A.%20Sensitivity%20and%20specificity%20of%20CD19.CAR-T%20cell%20detection%20by%20flow%20cytometry%20and%20PCR.%20Cells.%202021;10(11):3208." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12372207/bin/13046_2025_3475_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (30.1MB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Experimental &amp; Clinical Cancer Research : CR are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s13046-025-03475-8"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13046_2025_Article_3475.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.4Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372207/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372207/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372207%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372207/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372207/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372207/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40847369/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372207/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40847369/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372207/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372207/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="jskrvvYbPn4gmxVn4sQWkCizmR2RwFkffij84kGLulSLVGCLWBtyxXR6nyT0FS2I">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
